Comprehensive analysis of genes involved in the malignancy of gastrointestinal stromal tumors

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2705-2712

  Tsumuraya, Miyako ^a   Kato, Hiroyuki ^a   Miyachi, Kazuhito ^a   Sasaki, Kinro ^a   Tsubaki, Masahiro ^a   Akimoto, Kazumi ^a   Sunagawa, Masakatsu ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

ALT; C KIT gene; Gastrointestinal stromal tumor; GIST; Ki 67 labeling index; PI3K

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ADENOSINE DEAMINASE; APC PROTEIN; BETA 2 MICROGLOBULIN; BETA ACTIN; CASEIN KINASE II; CASPASE 9; CYCLIN DEPENDENT KINASE INHIBITOR 1B; FAS LIGAND; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH HORMONE RECEPTOR; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN CDC42; PROTEIN FOS; PROTEIN P130; PROTEIN SHC; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STEM CELL FACTOR RECEPTOR; THIOL ESTER HYDROLASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXC2; TUBERIN; UNINDEXED DRUG; WNT1 PROTEIN; ZINC FINGER PROTEIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CELL PROLIFERATION; CLINICAL ARTICLE; DUODENUM; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HIGH RISK PATIENT; HUMAN; LIVER; MALE; MESENTERY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RECTUM; SMALL INTESTINE; STOMACH;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-KIT; STOMACH NEOPLASMS;

EID: 77955811116     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, Sablinska K and Kindblom LG: Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden. Cancer 103: 821-829, 2005. (Pubitemid 40216412)
2. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y and Kitamura Y: Gain-of-function mutations of C-KIT in human gastrointestinal stromal tumors. Science 279: 577-580, 1998. (Pubitemid 28067289)
3. Corless CL, Schroeder A, Griffith D, Town A, McGreevey L, Harrell P, Shiraga S, Bainbridge T, Morich J and Heinrich MC: PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 23: 5357-5364, 2005.
4. Tarn C, Merkel E, Canutescu AA, Shen W, Skorobogatko Y, Heslin MJ, Eisenberg B, Birbe R, Patchefsky A, Dunbrack R, Arnoletti JP, von Mehren M and Godwin AK: Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Clin Cancer Res 11: 3668-3677, 2005.
5. Corless CL, Fletcher JA and Heinrich MC: Biology of gastrointestinal stromal tumors. J Clin Oncol 22: 3813-3825, 2004.
6. Kitamura Y and Hirota S: Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci 61: 2924-2931, 2004. (Pubitemid 40104590)
7. Lasota J, Stachura J and Miettinen M: GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology. Lab Invest 86: 94-100, 2006. (Pubitemid 43250972)
8. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH and Weiss SW: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 33: 459-465, 2002. (Pubitemid 34747864)
9. th ed. Rosai J (ed.). Missouri: Mosby-year Book, Inc, pp. 645-647, 1996.
10. Nakatani H, Kobayashi M, Jin T, Taguchi T, Sugimoto T, Nakano T, Hamada S and Araki K: STI571 (Glivec) inhibits the interaction between C-KIT and heat-shock protein 90 of the gastrointestinal stromal tumor cell line, GIST-T1. Cancer Sci 96: 116-119, 2005. (Pubitemid 40425387)
11. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S and Fletcher JA: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21: 4342-4349, 2003.
12. Lux ML, Rubin BP, Biase TL, Chen CJ, Maclure T, Demetri G, Xiao S, Singer S, Fletcher CD and Fletcher JA: KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 156: 791-795, 2000.
13. Gumurdulu D, Erdogan S, Kayaselcuk F, Seydaoglu G, Parsak CK, Demircan O and Tuncer I: Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters. World J Gastroenterol 13: 426-431, 2007. (Pubitemid 46178978)
14. Fujimoto Y, Nakanishi Y, Yoshimura K and Shimoda T: Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 6: 39-48, 2003. (Pubitemid 36460555)
15. Li L, Plummer SJ, Thompson CL, Tucker TC and Casey G: Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk. Clin Cancer Res 14: 633-637, 2008. (Pubitemid 351231141)
16. Thrasher AJ: WASp in immune-system organization and function. Nat Rev Immunol 2: 635-646, 2002.
17. Haller F, Happel N, Schulten HJ, von Heydebreck A, Schwager S, Armbrust T, Langer C, Gunawan B, Doenecke D and Füzesi L: Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors. Mod Pathol 20: 1103-1111, 2007.